Biology of CNS lymphoma and the potential of novel agents.

about

Biology of CNS lymphoma and the potential of novel agents.

Item

http://www.wikidata.org/entity/Q45985951

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Biology of CNS lymphoma and the potential of novel agents.

@en

Biology of CNS lymphoma and the potential of novel agents.

@nl

type

Item

label

Biology of CNS lymphoma and the potential of novel agents.

@en

Biology of CNS lymphoma and the potential of novel agents.

@nl

prefLabel

Biology of CNS lymphoma and the potential of novel agents.

@en

Biology of CNS lymphoma and the potential of novel agents.

@nl

P1476

Biology of CNS lymphoma and the potential of novel agents.

@en

P2093

James L Rubenstein

http://www.w3.org/2001/XMLSchema#string

P2860

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Oncogenically active MYD88 mutations in human lymphoma

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.

Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.

Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial.

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

P304

556-564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1182/ASHEDUCATION-2017.1.556

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29222305

http://www.w3.org/2001/XMLSchema#string

P932

6053314

http://www.w3.org/2001/XMLSchema#string